Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/87445
Full metadata record
DC FieldValueLanguage
dc.creatorJoão Filipe Urze de Almeida
dc.date.accessioned2025-11-08T12:50:39Z-
dc.date.available2025-11-08T12:50:39Z-
dc.date.issued2015-12-14
dc.date.submitted2016-03-08
dc.identifier.othersigarra:118561
dc.identifier.urihttps://hdl.handle.net/10216/87445-
dc.language.isopor
dc.rightsopenAccess
dc.subjectCiências da saúde
dc.subjectHealth sciences
dc.titleDesatinib as an Option to Treat P-cadherin Overexpressing Poor Prognosis Breast Cancer
dc.typeDissertação
dc.contributor.uportoInstituto de Ciências Biomédicas Abel Salazar
dc.identifier.doi10.34626/513q-z748
dc.identifier.tid201072840
dc.subject.fosCiências médicas e da saúde::Ciências da saúde
dc.subject.fosMedical and Health sciences::Health sciences
thesis.degree.disciplineMestrado em Oncologia
thesis.degree.grantorInstituto de Ciências Biomédicas Abel Salazar
thesis.degree.grantorUniversidade do Porto
thesis.degree.level1
Appears in Collections:ICBAS - Dissertação

Files in This Item:
File Description SizeFormat 
118561.pdfDesatinib as an Option to Treat P-cadherin Overexpressing Poor Prognosis Breast Cancer4.14 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.